Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

ClinicalTrials.gov ID: NCT06940141

Public ClinicalTrials.gov record NCT06940141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Aug 3, 2026, 4:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Rademikibart as an Add-on Treatment for Acute Exacerbation in Adult and Adolescent Participants With Asthma and Type 2 Inflammation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2, randomized, multicenter study in adult and adolescent participants with asthma and type 2 inflammation

Study identification

NCT ID
NCT06940141
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Connect Biopharm LLC
Industry
Enrollment
160 participants

Conditions and interventions

Conditions

Interventions

Drug · Combination Product

Eligibility (public fields only)

Age range
12 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 7, 2025
Primary completion
Jul 12, 2026
Completion
Aug 9, 2026
Last update posted
Jun 22, 2026

2025 – 2026

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Leland Stanford Junior University, Stanford Hospital Palo Alto California 94304
Amicis Research Center Valencia California 91355
Nemours Children's Hospital - DE Wilmington Delaware 19803
Nemours Children's Health Jacksonville Florida 32207
Pharmax Research of South Florida, Inc. Miami Florida 33175
Columbus Clinical Services, LLC Miami Florida 33215
Nemours Children's Health, Lake Nona Orlando Florida 32827
Health Synergy Clinical Research, LLC West Palm Beach Florida 33407
Primeway Clinical Research Group Fayetteville Georgia 30214
Pivotal Research Solutions Stonecrest Georgia 30038
University of Iowa Iowa City Iowa 52242
University of Kansas Medical Center Kansas City Kansas 66160
Allergy & Asthma Specialists, P.S.C. Owensboro Kentucky 42301
Chesapeake Clinical Research, Inc. White Marsh Maryland 21162
Washington University School of Medicine St Louis Missouri 63110
The Ohio State University Wexner Medical Center Columbus Ohio 43210
Clinical Research of Rock Hill Rock Hill South Carolina 29732
Inquest Clinical Research Baytown Texas 77521
Premier Pulmonary Critical Care and Sleep Medicine Denison Texas 75020
DCT- McAllen Primary Care Research, LLC dba Discovery Clinical Trials McAllen Texas 78503
Vermont Lung Center Colchester Vermont 05446

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.

Recently updated Asthma Acute trials

Other public records listing Asthma Acute. Sorted by last update posted; newest first. Not a recommendation.

All Asthma Acute trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06940141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2026 · Synced Aug 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06940141 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →